// App-Quantinova.ai

e17094 : Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrence ovarian cancer ( ROC) patients with BRCA 1/2 mutation. A monoistitutional experience.

Researchers

Presenter

  • Giuseppa Scandurra

Principal Investigators

  • Francesco Marletta

  • Sara Nicolini

  • Giuseppe Luigi Banna

  • Andrea Bendetto Di Stefano

  • Stefania Cali'

  • Grazia Acquaviva

  • Giuseppe Corsaro

  • Maria Tamburo

  • Giuseppe Scibilia

  • Paolo Scollo

Medical Centers

  • Oncologia Medica Ospedale per le Emergenze Cannizzaro, Catania, Italy

  • U.O.C. Radioterapia Azienda Ospedaliera per le Emergenze Cannizzaro, Catania, Italy

  • University Magna Graecia Catanzaro, Catanzaro, Italy

  • Cannizzaro Hospital, Catania, Italy

  • Unita Operativa di Ginecologia Oncologica Dipartimento Materno Infantile Azienda Ospedaliera Cannizzaro, Catania, Italy

  • U.O.C. Radioterapia Azienda Ospedaliera per le Emergenze Cannizzaro, Catania, Italy

  • Unita Operativa Ostetricia e Ginecologia.Dipartimento Materno Infantile Ospedale Cannizzaro di Catania, Catania, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Endometrial Cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • BRCA mutation

Drug/Treatment

  • Carboplatin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved